Výsledky vyhledávání - Oddbjørn Straume
- Zobrazuji výsledky 1 - 19 z 19
-
1
-
2
-
3
-
4
Bevacizumab therapy for POEMS syndrome Autor Oddbjørn Straume, Jann Bergheim, Peter Ernst
Vydáno 2006Carta -
5
-
6
Tumor‐vascular interactions and tumor dormancy Autor George N. Naumov, Judah Folkman, Oddbjørn Straume, Lars A. Akslen
Vydáno 2008Revisão -
7
-
8
-
9
-
10
-
11
-
12
The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases Autor Hanna Dillekås, Romano Demicheli, Ilaria Ardoino, Svein Arthur Jensen, Elia Biganzoli, Oddbjørn Straume
Vydáno 2016Artigo -
13
-
14
A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare Autor Rajiv Kumar, Johanna Smeds, Petra Berggren, Oddbjørn Straume, Barbro Lundh Rozell, Lars A. Akslen, Kari Hemminki
Vydáno 2001Artigo -
15
Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension Autor Cornelia Schuster, Hans Petter Eikesdal, Hanne Puntervoll, Jürgen Geisler, Stephanie Geisler, Daniel Heinrich, Anders Molven, Per Eystein Lønning, Lars A. Akslen, Oddbjørn Straume
Vydáno 2012Artigo -
16
A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype Autor George N. Naumov, Elise R. Bender, David Zurakowski, Soo-Young Kang, David A. Sampson, Evelyn Flynn, Randolph S. Watnick, Oddbjørn Straume, Lars A. Akslen, Judah Folkman, Nava Almog
Vydáno 2006Artigo -
17
Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance Autor George N. Naumov, Monique B. Nilsson, Tina Cascone, Alexandra Briggs, Oddbjørn Straume, Lars A. Akslen, Eugene Lifshits, Lauren A. Byers, Li Xu, Hua-Kang Wu, Pasi A. Jänne, Susumu Kobayashi, Balázs Halmos, Daniel G. Tenen, Xiaoou Tang, Jeffrey A. Engelman, Beow Y. Yeap, Judah Folkman, Bruce E. Johnson, John V. Heymach
Vydáno 2009Artigo -
18
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer Autor Oddbjørn Straume, Takeshi Shimamura, Michael Lampa, Julián Carretero, Anne M. Øyan, Di Jia, Christa L. Borgman, Margaret Soucheray, Sean R. Downing, Sarah M. Short, Soo-Young Kang, Souming Wang, Liang Chen, Karin Collett, Ingeborg Bachmann, Kwok‐Kin Wong, Geoffrey I. Shapiro, Karl H. Kalland, Judah Folkman, Randolph S. Watnick, Lars A. Akslen, George N. Naumov
Vydáno 2012Artigo -
19
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma Autor Yanina Jansen, Elisa A. Rozeman, Robert M. Mason, Simone M. Goldinger, Marnix H. Geukes Foppen, Lise Hoejberg, Henrik Schmidt, Johannes V. van Thienen, John B.A.G. Haanen, Leena Tiainen, Inge Marie Svane, Siru Mäkelä, Teofila Seremet, Ana Arance, Reinhard Dummer, Lars Bastholt, Marta Nyakas, Oddbjørn Straume, Alexander M. Menzies, Georgina V. Long, Victoria Atkinson, Christian U. Blank, Bart Neyns
Vydáno 2019Artigo
Vyhledávací nástroje:
Související témata
Medicine
Cancer research
Internal medicine
Biology
Melanoma
Pathology
Cancer
Genetics
Gene
Oncology
Angiogenesis
Disease
Immunohistochemistry
Receptor
Surgery
VEGF receptors
Vascular endothelial growth factor
Bevacizumab
Biochemistry
Chemotherapy
Growth factor
Immunology
Metastasis
Tissue microarray
Allele
Antibody
Basic fibroblast growth factor
Botany
Breast cancer
CDKN2A